Methyl 2-[(5-bromopyridin-2-yl)(methyl)amino]acetate

Catalog No. :
ACRXWF123
CAS No. :
1249621-29-1
Molecular Formula :
C9H11BrN2O2
Molecular Weight :
259.10

IUPAC Name:methyl N-(5-bromopyridin-2-yl)-N-methylglycinate

Methyl 2-[(5-bromopyridin-2-yl)(methyl)amino]acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$127.00Login to see priceInquiryInquiry
1g95%$600.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-[(5-bromopyridin-2-yl)(methyl)amino]acetate
IUPAC Namemethyl N-(5-bromopyridin-2-yl)-N-methylglycinate
MDL No.MFCD16161353
Molecular FormulaC9H11BrN2O2
Molecular Weight259.10
SMILESO=C(OC)CN(C1=NC=C(Br)C=C1)C
InChI KeyJMIRMVNRITVCMZ-UHFFFAOYSA-N
Synonymmethyl 2-((5-bromopyridin-2-yl)(methyl)amino)acetate;Glycine, N-(5-bromo-2-pyridinyl)-N-methyl-, methyl ester;Methyl N-(5-bromopyridin-2-yl)-N-methylglycinate;N-(5-Bromo-2-pyridinyl)-N-methylglycine methyl ester
CAS No.1249621-29-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRXWF123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQGVW058 route compound structure diagram
    ACQGVW05813515-93-0 In Stock
  2. Plus
  3. ACIWBF532 route compound structure diagram
    ACIWBF532766-11-0 In Stock
  4. Then
  5. ACRXWF123 route product structure diagram
    ACRXWF1231249621-29-1 In Stock
Inquiry

2. ACRXWF123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXWF123 route product structure diagram
    ACRXWF1231249621-29-1 In Stock
Inquiry

Comments (0)